This pilot study aims at exploring the efficacy of iTBS compared to 10Hz protocol and explore potential biomarkers of treatment response
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
20
Non-Invasive Neurostimulation Therapies lab, University of British Columbia
Vancouver, British Columbia, Canada
Change in the Hamilton Depression Rating scale 17-item (HDRS-17) score
A 50% improvement in the score is considered response to rTMS. A final score of \<8 is categorized as remission.
Time frame: baseline, 1, 4, and 12 weeks post-treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.